To continue reading this article, sign up for FREE to
Membership is FREE
and provides you with
instant access
to email newsletters, digital publications, our full content catalogue & more...
Applied Biosystems Completes Equity Investment in VisiGen
Applied Biosystems Group, an Applera Corporation business, has announced that it has completed its previously announced equity investment in privately held VisiGen Biotechnologies.
Concurrent with its investment, Applied Biosystems also entered into a scientific collaboration agreement with VisiGen.
The VisiGen investment is part of Applied Biosystems’ strategy of maintaining its position in DNA sequencing by complementing its internal investments in new and existing sequencing technologies with promising next-generation approaches.
VisiGen’s technological approach to DNA sequencing is based on the ability to analyze a single molecule of DNA in real-time.
Add Technology Networks as a preferred Google source to see more of our trusted coverage.
